Sei-Ichiro Motegi Selected Research

Pilomatrixoma

1/2020	Six cases of perforating pilomatricoma: Anetodermic changes with expression of matrix metalloproteinases.
4/2018	Pilomatricoma with bullous-like/anetodermic appearance: Possibly associated with matrix metalloproteinases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sei-Ichiro Motegi Research Topics

Disease

15	Systemic Scleroderma (Systemic Sclerosis) 07/2021 - 11/2013
11	Dermatomyositis (Dermatopolymyositis) 11/2021 - 08/2016
10	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2022 - 07/2014
9	Fibrosis (Cirrhosis) 10/2021 - 09/2014
6	Pressure Ulcer (Bedsore) 07/2021 - 01/2016
6	Reperfusion Injury 07/2021 - 03/2015
6	Neoplasms (Cancer) 01/2021 - 07/2006
6	digital ulcers 03/2018 - 11/2014
5	Wounds and Injuries (Trauma) 02/2021 - 04/2015
5	Melanoma (Melanoma, Malignant) 01/2021 - 06/2003
5	Suppuration 01/2020 - 01/2016
5	Sclerosis 01/2019 - 07/2014
3	Nephrogenic Fibrosing Dermopathy 01/2021 - 09/2014
3	Ischemia 01/2020 - 05/2018
3	Hypoxia (Hypoxemia) 01/2019 - 11/2015
2	Disease Progression 05/2022 - 08/2021
2	Polymyositis 02/2022 - 01/2021
2	Atopic Dermatitis (Atopic Eczema) 01/2022 - 01/2022
2	Autoimmune Diseases (Autoimmune Disease) 11/2021 - 01/2021
2	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2021 - 01/2021
2	Werner Syndrome (Werner's Syndrome) 02/2021 - 01/2016
2	Pain (Aches) 02/2021 - 07/2017
2	Ulcer 02/2021 - 02/2021
2	Dermatitis 01/2021 - 08/2020
2	Peripheral Arterial Disease 01/2021 - 11/2014
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 02/2017
2	Pilomatrixoma 01/2020 - 04/2018
2	Dermatofibrosarcoma 12/2019 - 01/2019
2	Eosinophilia 01/2019 - 07/2013
2	Amyloidosis 05/2018 - 08/2017
2	Rheumatoid Arthritis 01/2018 - 02/2015
2	Acro-Osteolysis (Acroosteolysis) 02/2015 - 11/2014
2	Angioedema 02/2014 - 07/2013
1	Merkel Cell Carcinoma 09/2022
1	Pericarditis 02/2022
1	Leukoencephalopathies 02/2022
1	Cerebral Infarction 02/2022
1	Obesity 01/2022
1	Mediastinal Emphysema (Pneumomediastinum) 01/2022
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2021
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 09/2021
1	Callosities 02/2021
1	Infections 02/2021

Drug/Important Bio-Agent (IBA)

7	AntibodiesIBA 02/2022 - 06/2003
6	Proteins (Proteins, Gene)FDA Link 09/2022 - 06/2003
6	Bleomycin (Blenoxane)FDA LinkGeneric 10/2021 - 10/2018
5	Botulinum Toxins (Botulinum Toxin)IBA 07/2021 - 07/2017
4	batrachotoxinin A 20-alpha-benzoateIBA 07/2021 - 07/2017
4	AutoantibodiesIBA 01/2021 - 01/2018
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 12/2014
3	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2022 - 08/2016
3	indium-bleomycinIBA 10/2021 - 01/2019
3	Pharmaceutical PreparationsIBA 12/2020 - 01/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 07/2013
2	Glycoproteins (Glycoprotein)IBA 02/2022 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 11/2015
2	baricitinibIBA 01/2022 - 01/2022
2	SteroidsIBA 01/2022 - 01/2016
2	Collagen Type I (Type I Collagen)IBA 10/2021 - 01/2019
2	Methionine (L-Methionine)FDA Link 01/2021 - 11/2014
2	CytokinesIBA 01/2021 - 06/2017
2	HomocysteineIBA 01/2021 - 11/2014
2	Amino Acids FDA Link 01/2021 - 11/2014
2	ZincIBA 08/2020 - 08/2019
2	ApelinIBA 01/2020 - 10/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 04/2018
2	Adenosine Triphosphate (ATP)IBA 08/2019 - 01/2019
2	LigandsIBA 01/2019 - 11/2008
2	Small Interfering RNA (siRNA)IBA 10/2018 - 11/2015
2	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 05/2018 - 08/2017
2	Immunoglobulins (Immunoglobulin)IBA 05/2018 - 12/2014
2	Type A Botulinum Toxins (Botox)FDA Link 05/2018 - 03/2015
2	Collagen Type IV (Type IV Collagen)IBA 05/2017 - 02/2017
2	Endothelin-1 (Endothelin 1)IBA 11/2015 - 09/2014
2	RNA Polymerase IIIIBA 02/2015 - 07/2014
2	anti-scl-70 autoantibodiesIBA 11/2014 - 07/2014
2	Chemokine CCL26IBA 01/2014 - 07/2013
1	Biomarkers (Surrogate Marker)IBA 09/2022
1	Interleukin-22 (IL-22)IBA 01/2022
1	InterferonsIBA 11/2021
1	Interferon Type IIBA 11/2021
1	Retroelements (Retrotransposon)IBA 11/2021
1	secukinumabIBA 08/2021
1	Therapeutic UsesIBA 07/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2021
1	Transfer RNA (tRNA)IBA 02/2021
1	Ligases (Synthetase)IBA 02/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 02/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021
1	Contrast MediaIBA 01/2021

Therapy/Procedure

7	Therapeutics 05/2022 - 11/2017
3	Injections 01/2021 - 07/2017
2	Subcutaneous Injections 12/2017 - 06/2017
1	Transplantation 09/2021
1	Debridement 02/2021
1	Conservative Treatment 02/2021
1	Operative Surgical Procedures 02/2021
1	Minimally Invasive Surgical Procedures 02/2021